Peter Diamandis
Founder/co-founder of XPRIZE, Singularity University, Human Longevity Inc., and more
Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world's leaders on exponentially growing technologies.
As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is co-founder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company.
Visit website: https://www.diamandis.com/
See also: 
XPRIZE
- Non-profit organization that designs and hosts public competitions intended to encourage technological development
Details last updated 24-Jun-2019
Peter Diamandis is also referenced in the following:
Global Healthspan Summit 2023
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
XPRIZE Launches a $101 Million Health Competition
Live stream of XPRIZE Healthspan launch on YouTube
Peter Diamandis Creations
Abundance
Manifesto for the future that is grounded in practical solutions written by Peter H. Diamandis
Peter Diamandis News
XPRIZE Launches a $101 Million Healthspan Competition
Live Forever Club - 29-Nov-2023
10 years of functional age-reversal in 65-80 year olds within the next 7 years... bring it on!!!
Read more...Peter Diamandis launches new $250 million stem cells company
TechCrunch - 15-Feb-2018
Celularity is a spinout from Celgene, a global biopharmaceutical company. Hopes to use stem cell...
Read more...Peter Diamandis - Longevity Escape Velocity
Aging Reversed - 06-Jun-2017
Interesting interview with Peter Diamandis - founder of the X Prize Foundation and Singularity Un...
Read more...Human Longevity Inc aiming for 1 million genome study
Next Big Future - 16-Jun-2015
HLI (Human Longevity Inc) has purchased two Illumina HiSeq X Ten Sequencing Systems to study inte...
Read more...Articles written by Peter Diamandis
AI reduces drug discovery from years to days - and that's just the start
Singularity Hub - 23-Jul-2020
Insilico Medicine is slashing the cost of drug development
Read more...
